Synthesis and evaluation of bis-dipeptide and bis-tripeptide analogs of actinomycin D
- 1 July 1978
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 21 (7) , 607-612
- https://doi.org/10.1021/jm00205a004
Abstract
Six bis-dipeptide analogues of actinomycin D, all containing 2 threonyl-D-valine side chains, were prepared. Also 2 bis-tripeptide analogues containing an additional proline or oxoproline residue were synthesized. None of the compounds bound to DNA in a manner similar to actinomycin D. This lack of strong intercalative binding emphasizes the importance of the pentapeptidolactone side chains in the binding of actinomycin D to DNA and also highlights the deficiencies inherent in using only small nucleotide sequences in investigating drug-DNA binding. None of the analogues tested showed any antitumor activity, although actinocylbis(threonyl-D-valine methyl ester) did show 10% of the antibacterial activity of actinomycin D vs. Bacillus subtilis.This publication has 5 references indexed in Scilit:
- Visualization of drug-nucleic acid interactions at atomic resolutionJournal of Molecular Biology, 1977
- Phosphorus-31 nuclear magnetic resonance studies of actinomycin D, ethidium bromide, and 9-aminoacridine complexes with dinucleotidesBiochemistry, 1977
- Studies of the binding of actinomycin and related compounds to DNAJournal of Molecular Biology, 1968
- Actinomycin binding to DNA: Mechanism and specificityJournal of Molecular Biology, 1965
- Actinomycin and Nucleic Acid FunctionProgress in Nucleic Acid Research and Molecular Biology, 1964